DD

Dr. Dmitrij Hristodorov

General Partner at Forbion

Munich, Bavaria

Skills

Life Sciences
Business Development
Ophthalmology
Immunology
Biotechnology
Licensing
Cancer Research
Inflammation
Pharmaceutical Industry
Drug Development

Education

Work Experience

F
Forbion

2020

  • General Partner

    2024

  • Partner

    2021 - 2024

  • Principal

    2021 - 2021

  • Senior Associate

    2020 - 2020

BT
Beacon Therapeutics

2024

  • Board Member

    2024

Progentos Therapeutics

2024

  • Board Member

    2024

K
Kynexis

2022

  • Board Member

    2022

AB
AAVantgarde Bio

2023

  • Board Member

    2023

ST
Seamless Therapeutics

2022

  • Board Member

    2022

    New gene editing platform based on recombinases

CT
Complement Therapeutics

2022

  • Board Member

    2022

RT
RyCarma Therapeutics

2021

  • Board Member

    2021

    Targeting RyR1/2 to treat cardiac, musculoskeletal and neurological diseases.

RB
Rampart Bioscience

2023 - 2025

  • Board Member

    2023 - 2025

O
Oxular

2021 - 2024

  • Board Member

    2021 - 2024

    One treatment a year. Life changing.